GALE – HedgeChatter

Galena Biopharma Acquires Abstral(R) (fentanyl) Sublingual Tablets in U.S., a Novel, Best-in-Class Treatment Approved for Breakthrough Cancer Pain

[at noodls] – AbstralÂ® was approved in the U.S. in 2011 and is the first and only fentanyl sublingual tablet for the management of breakthrough cancer pain in opioid tolerant patients. AbstralÂ® product launch targeted … moreView todays social media effects on GALEView the latest stocks trending across Twitter. Click to view dashboardSee who Galena is hiring next, click here […]

March 18, 2013 Bystocknews GALE, stock Comments Off read more

Galena Biopharma Receives 2013 Global Frost & Sullivan Award for New Product Innovation for NeuVax(TM)

[at noodls] – LAKE OSWEGO, Ore., March 14, 2013 (GLOBE NEWSWIRE) — Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs … moreView todays social media effects on GALEView the latest stocks trending across Twitter. Click to view dashboardSee who Galena is hiring next, click here to view […]

March 14, 2013 Bystocknews GALE, stock Comments Off read more

Galena Biopharma to Present at the 25th Annual ROTH Conference

[at noodls] – LAKE OSWEGO, Ore., March 11, 2013 (GLOBE NEWSWIRE) — Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical … moreView todays social media effects on GALEView the latest stocks trending across Twitter. Click to view dashboardSee who Galena is hiring next, click here to view […]

March 11, 2013 Bystocknews GALE, stock Comments Off read more

Galena Biopharma to Present at the 7th Annual Bio-Europe International Partnering Conference

[at noodls] – LAKE OSWEGO, Ore., March 4, 2013 (GLOBE NEWSWIRE) — Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical … moreView todays social media effects on GALEView the latest stocks trending across Twitter. Click to view dashboardSee who Galena is hiring next, click here to view […]

March 4, 2013 Bystocknews GALE, stock Comments Off read more

Galena Biopharma to Present at the 15th Annual Bio CEO & Investor Conference

[at noodls] – LAKE OSWEGO, Ore., Feb. 5, 2013 (GLOBE NEWSWIRE) — Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical … moreView todays social media effects on GALEView the latest stocks trending across Twitter. Click to view dashboardSee who Galena is hiring next, click here to view […]

February 5, 2013 Bystocknews GALE, stock Comments Off read more

Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants

[at noodls] – LAKE OSWEGO, Ore., Dec. 18, 2012 (GLOBE NEWSWIRE) — Galena Biopharma (Nasdaq:GALE) announced today the pricing of an underwritten public offering of 15,156,250 units at a public offering price of $1.60 … moreView todays social media effects on GALEView the latest stocks trending across Twitter. Click to view dashboardSee who Galena is hiring next, click here to […]

December 18, 2012 Bystocknews GALE, stock Comments Off read more

Galena Biopharma Announces Public Offering of Common Stock and Warrants

[at noodls] – LAKE OSWEGO, Ore., Dec. 17, 2012 (GLOBE NEWSWIRE) — Galena Biopharma (Nasdaq:GALE) announced today that it intends to offer shares of its common stock and warrants to purchase shares of its common stock … moreView todays social media effects on GALEView the latest stocks trending across Twitter. Click to view dashboardSee who Galena is hiring next, click […]

December 17, 2012 Bystocknews GALE, stock Comments Off read more

Galena Biopharma Presents Final Landmark 60-Month Results From NeuVax(TM) Phase 1/2 Trials at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium

[at noodls] – The combined SN-33 (Node Positive) and SN-34 (Node Negative) Intent-to-treat (ITT) population continued to demonstrate an excellent safety and efficacy profile….This is an abstract of the original noodl. … moreView todays social media effects on GALEView the latest stocks trending across Twitter. Click to view dashboardSee who Galena is hiring next, click here to view […]

December 7, 2012 Bystocknews GALE, stock Comments Off read more

Galena Biopharma and Leica Biosystems Announce Partnership to Develop Companion Diagnostic for HER2 Screening in Women With Breast Cancer

[at noodls] – Leica Biosystems will develop a fully automated HER2 diagnostic to support identification of appropriate HER2 negative (IHC 1+/2+) patients for NeuVaxâ„¢ (nelipepimut-S or E75) Galena strengthens its NeuVax … moreView todays social media effects on GALEView the latest stocks trending across Twitter. Click to view dashboardSee who Galena is hiring next, click here to view […]

December 6, 2012 Bystocknews GALE, stock Comments Off read more

Galena Biopharma Announces NeuVax(TM) Poster Presentations at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium

[at noodls] – LAKE OSWEGO, Ore., Nov. 29, 2012 (GLOBE NEWSWIRE) — Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical … moreView todays social media effects on GALEView the latest stocks trending across Twitter. Click to view dashboard […]

November 29, 2012 Bystocknews GALE, stock Comments Off read more